Home › Funds › Prospect Capital Advisors, LLC › ETON
Prospect Capital Advisors, LLC position in ETON
ETON PHARMACEUTICALS INC · Health Care
Prospect Capital Advisors, LLC reported holding 145,900 shares of ETON (ETON PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$7.5M, representing 3.70% of its reported portfolio and ranking #12 among its reported holdings. Prospect Capital Advisors, LLC has disclosed ETON holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Prospect Capital Advisors, LLC's ETON position evolved
Prospect Capital Advisors, LLC first disclosed a stake in ETON in Q2 2026 at 157,200 shares (US$5.7M). The position peaked in Q3 2026 at 145,900 shares, worth US$7.5M. Across 2 filings, Prospect Capital Advisors, LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 145,900 shares valued at US$7.5M — a reduction of -11,300 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 157.20K | $5.69M | New |
| Q3 2026 | 145.90K | $7.51M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ETON and 13F data
ETON (ETON PHARMACEUTICALS INC) is a Health Care company. 73 other funds we track also report a position in ETON — the largest reported positions include EcoR1 Capital, LLC (US$127.2M), Opaleye Management Inc. (US$103.5M), Nantahala Capital Management, LLC (US$45.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ETON
- EcoR1 Capital, LLC 2.47M sh · $127.23M · Q3 2026
- Opaleye Management Inc. 2.86M sh · $103.53M · Q2 2026
- Nantahala Capital Management, LLC 875.51K sh · $45.08M · Q3 2026
- National Philanthropic Trust 492.11K sh · $25.34M · Q3 2026
- Westside Investment Management, Inc. 401.38K sh · $20.67M · Q3 2026
- Soleus Capital Management, L.P. 308.10K sh · $15.86M · Q3 2026
- Pillsbury Lake Capital LLC 288.27K sh · $14.84M · Q3 2026
- Panoramic Capital, LLC 192.65K sh · $9.92M · Q3 2026
- Lumbard & Kellner, LLC 173.26K sh · $8.92M · Q3 2026
- Grandeur Peak Global Advisors, LLC 161.83K sh · $8.33M · Q3 2026
- Informed Momentum Co LLC 139.21K sh · $7.17M · Q3 2026
- PRELUDE CAPITAL MANAGEMENT, LLC 97.58K sh · $5.02M · Q3 2026
More on Prospect Capital Advisors, LLC
FAQ
How long has Prospect Capital Advisors, LLC held ETON?
Prospect Capital Advisors, LLC has disclosed ETON holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is Prospect Capital Advisors, LLC's current position in ETON?
As of Q3 2026, Prospect Capital Advisors, LLC holds 145.90K shares of ETON (ETON PHARMACEUTICALS INC), valued at $7.51M, representing 3.70% of its reported portfolio and ranking #12.
Has Prospect Capital Advisors, LLC been buying or selling ETON?
In the latest 13F filing (Q3 2026), Prospect Capital Advisors, LLC reduced its position in ETON. The position peaked in Q3 2026 at 145.90K shares.
Which other funds hold ETON?
Other major institutional holders of ETON include EcoR1 Capital, LLC, Opaleye Management Inc., Nantahala Capital Management, LLC, among 73 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.